###begin article-title 0
Genetic variation in the transforming growth factor-beta1 gene is associated with susceptibility to IgA nephropathy
###end article-title 0
###begin p 1
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Background.</bold>
###xml 176 181 176 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
Background. There is growing evidence of genetic risk for susceptibility to IgA nephropathy. Among several candidate genes related to immunological regulation in renal tissue, TGFB1 is known to be a contributor to proliferation and the development of fibrosis.
###end p 1
###begin p 2
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods.</bold>
###xml 116 124 <span type="species:ncbi:9606">patients</span>
###xml 130 133 <span type="species:ncbi:9606">men</span>
###xml 141 146 <span type="species:ncbi:9606">women</span>
###xml 189 192 <span type="species:ncbi:9606">men</span>
###xml 201 206 <span type="species:ncbi:9606">women</span>
Methods. We analysed several SNPs in a region of this gene using 212 DNA samples from biopsy-proven IgA nephropathy patients, 146 men and 66 women and 477 healthy age-matched controls (321 men and 156 women) from the same population in Sweden.
###end p 2
###begin p 3
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Results.</bold>
###xml 220 221 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 296 297 294 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 447 448 443 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 469 470 465 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 543 544 539 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 565 566 561 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 633 638 629 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 741 746 737 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 159 167 <span type="species:ncbi:9606">patients</span>
###xml 682 690 <span type="species:ncbi:9606">patients</span>
###xml 814 821 <span type="species:ncbi:9606">patient</span>
###xml 899 907 <span type="species:ncbi:9606">patients</span>
Results. Frequencies of four out of five selected SNPs (rs6957, rs2241715, rs1800471, rs1982073 and rs1800469) were found to significantly differ between male patients and male controls in a co-dominant model (corrected P </= 0.05) and of two SNPs (rs1982073 and rs1800469) in the allelic model (P </= 0.05 in 100 000 permutation test). Haplotype analysis for five selected SNPs revealed a significant association of TGGCG with protective effect (P = 0.0012, empirical P = 0.006, 100 000 permutations) and of CTGTA with susceptibility effect (P = 0.0018, empirical P = 0.008, 100 000 permutations). In our study, no association with TGFB1 variations was found when comparing female patients and female controls. No association was found for TGFB1 markers with disease progression for selected individuals from the patient's group. In addition, meta-analysis performed for SNP rs1982073 for combined patients and controls from our study together with published data from two independent studies showed a significant association.
###end p 3
###begin p 4
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conclusions.</bold>
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
Conclusions. Our experimental data together with the meta-analysis suggest TGFB1 as an important candidate gene for further biological studies of IgA nephropathy and as a possible target for therapy. Our data also indicate a possibility of a gender effect in the genetic background of IgA nephropathy.
###end p 4
###begin title 5
Keywords
###end title 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 396 399 396 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R1 R2 R3">1&#8211;3</xref>
###xml 589 590 589 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R4">4</xref>
###xml 793 794 793 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R1">1</xref>
###xml 477 480 <span type="species:ncbi:9606">men</span>
###xml 652 660 <span type="species:ncbi:9606">patients</span>
IgA nephropathy is the most common form of glomerulonephritis identified in all regions of the world where renal biopsy is widely practiced. Evidence derived from experimental models of spontaneous IgA nephropathy and studies of the genetics, familial occurrence and racial differences in prevalence support the influence of genetic factors in the development and progression of IgA nephropathy [1-3]. IgA nephropathy in Caucasian populations was shown to be more prevalent in men; the ratio of males to females with IgA nephropathy is around 6:1 in northern Europe and the United States [4]. Poor prognostic factors for progression of renal damage in patients with IgA nephropathy are male gender, older age, presence of hypertension, moderate or severe proteinuria and severe renal lesions [1].
###end p 7
###begin p 8
###xml 317 318 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R5">5</xref>
###xml 472 475 460 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R6 R7">6,7</xref>
###xml 694 697 679 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R8 R9">8,9</xref>
###xml 456 461 <span type="species:ncbi:9606">human</span>
Transforming growth factor-beta1 (TGFbeta1) is a multifunctional cytokine that mediates cell proliferation, differentiation and other functions in different cell types. TGFbeta1 signalling is an essential mechanism in isotype switching to immunoglobulin A in B lymphocytes and up-regulates IgA production in general [5]. TGFbeta1 contributes to the expansion of mesangial matrix, development of fibrosis and cell proliferation both in animal models and in human diseases [6,7]. The kidney seems to be particularly sensitive to the powerful fibrogenic actions of TGFbeta1 that may contribute to fibrosis in most forms of renal diseases, leading to renal impairment and decreased renal function [8,9].
###end p 8
###begin p 9
###xml 19 24 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 208 209 205 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R8">8</xref>
###xml 210 212 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R10">10</xref>
###xml 213 215 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R11">11</xref>
###xml 255 257 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R12">12</xref>
###xml 285 290 279 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 451 455 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R9 R10">9,10</xref>
###xml 456 461 450 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R13 R14">13,14</xref>
###xml 44 49 <span type="species:ncbi:9606">human</span>
The TGFbeta1 gene, TGFB1, is located at the human chromosome 19q13.1-3 (omim 190180). There are several indications that genetic polymorphism of this gene is involved in the development of fibrotic diseases [8,10,11] and may regulate TGFbeta1 production [12]. Four previous studies of TGFB1 polymorphisms have demonstrated possible associations between susceptibility and/or severity of IgA nephropathy, but the results have so far been inconsistent [9,10,13,14].
###end p 9
###begin p 10
###xml 168 173 168 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 36 44 <span type="species:ncbi:9606">patients</span>
In the present study, 212 unrelated patients with biopsy-proven IgA nephropathy and 477 healthy subjects were selected for studies of five various polymorphisms in the TGFB1 gene with consideration to gender. In addition, a meta-analysis including previous studies was performed in order to clarify the role of TGFbeta1 as a possible susceptibility factor in IgA nephropathy.
###end p 10
###begin title 11
Materials and methods
###end title 11
###begin title 12
Subjects
###end title 12
###begin p 13
###xml 476 477 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 505 506 501 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 531 532 527 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 563 564 559 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 836 837 832 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 25 33 <span type="species:ncbi:9606">patients</span>
###xml 379 387 <span type="species:ncbi:9606">patients</span>
###xml 631 639 <span type="species:ncbi:9606">Patients</span>
###xml 791 799 <span type="species:ncbi:9606">patients</span>
A total of 212 unrelated patients (146 males and 66 females), mean age 38.5 +/- 14.4 (range 17-77 years) with biopsy-proven IgA nephropathy, all self-reported Caucasians, and 477 individually sex- and age-matched healthy Caucasians from a Swedish population (321 males and 156 females), mean age 44.8 +/- 13.0 (range 18-80 years), were included in the present investigation. The patients were recruited from the Department of Nephrology at the Karolinska University Hospital (n = 117), Danderyd Hospital (n = 31), Skovde Hospital (n = 36) and Linkoping Hospital (n = 28), representing a population from the central part of Sweden. Patients with Henoch-Schonlein purpura and other forms of glomerulonephritis were not included in the study. For known information about kidney function in the patients at the time of diagnosis, see Table 1.
###end p 13
###begin p 14
###xml 92 93 92 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 34 42 <span type="species:ncbi:9606">patients</span>
Glomerular filtration rate of the patients in the different stages of chronic kidney diseasea
###end p 14
###begin p 15
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aCalculated for individuals with available clinical data.
###end p 15
###begin p 16
###xml 4 12 <span type="species:ncbi:9606">patients</span>
All patients gave informed consent, and the study was approved by the Ethics Committee of the Karolinska Hospital, Stockholm, Sweden.
###end p 16
###begin title 17
Disease severity
###end title 17
###begin p 18
###xml 186 191 186 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 26 34 <span type="species:ncbi:9606">patients</span>
###xml 248 256 <span type="species:ncbi:9606">patients</span>
One hundred and seventeen patients from the Karolinska University Hospital, who had been followed up for up to 12 years since renal biopsy, were investigated for the correlation between TGFB1 genotype and disease severity. The average age of these patients at the time of renal biopsy was 37.0 +/- 13.2 years (range 17-77 years).
###end p 18
###begin p 19
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R15">15</xref>
###xml 460 461 458 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 579 580 575 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 605 606 601 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Glomerular filtration rate (GFR) was estimated from yearly serum creatinine measurements using the Modification of Diet in Renal Disease (MDRD) equation [15]. To investigate the correlation between genotype and disease severity, we used the following criteria: for benign disease, loss of GFR of <2 ml/min/year, for moderate progression loss of GFR of >/=2 to <5 ml/min/year or the progression to chronic kidney disease (CKD) stage 3 (GFR = 30-59 ml/min/1.73 m2), and for severe progression, loss of GFR of >/=5 ml/min/year or reaching CDK stage 4 or 5 (GFR = 15-29 ml/min/1.73 m2 and GFR<15 ml/min/1.73 m2).
###end p 19
###begin title 20
Selection of markers
###end title 20
###begin p 21
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 541 542 537 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
The TGFB1 gene in the HapMap database represents a sequence at chromosome 19q13.1 between two recombination blocks. We succeeded with five reproducible assays: in the promoter region at position -509, rs1800469 (C-509T), in the downstream 3' genomic region, rs6957, in the intron, rs2241715, and two in the signal sequence of exon 1, rs1800471 (C915G or codon 25, arginine-->proline) and rs1982073 (T869C or codon 10, leucine-->proline). More detailed information of all selected SNPs with the minor allele frequencies is presented in Table 2.
###end p 21
###begin p 22
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 51 59 <span type="species:ncbi:9606">patients</span>
Polymorphisms of the TGFB1 gene in IgA nephropathy patients
###end p 22
###begin p 23
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aMinor allele frequency from current study.
###end p 23
###begin p 24
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
bRestriction Endonuclease Mapping method.
###end p 24
###begin title 25
DNA and genotyping
###end title 25
###begin p 26
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R16">16</xref>
###xml 169 174 169 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R16">16</xref>
###xml 343 348 343 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 546 547 546 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
DNA was extracted from EDTA blood samples (5-10 ml) by the 'salting out' method as described elsewhere [16]. To identify codon 25 allele polymorphism (rs1800471) in the TGFB1 gene, the restriction endonuclease mapping method (REM) was used as previously described [16]. To detect other SNPs (rs6957, rs2241715, rs1982073 and rs1800469) of the TGFB1 gene, the TaqMan allelic discrimination assay (Applied Biosystems, Foster City, CA, USA) was used. Three out of four assays were commercially available and one was designed for this project (Table 2). TaqMan allelic discrimination was performed according to the standard protocol in a 384-well plate with 10 ng of DNA per sample. PCR was run in GeneAmp PCR System 9700 (Applied Biosystems), and the fluorescent signals from the hybridization probes were detected by a 7900 Sequence Detector (Applied Biosystems).
###end p 26
###begin p 27
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R17">17</xref>
To assess genotyping robustness, we re-genotyped a random subset of 191 cases and controls for rs1982073 SNP using the restriction endonuclease mapping method published previously [17], which resulted in a 99.5% match of genotyping calls with the TaqMan assay.
###end p 27
###begin p 28
All analysed markers were in Hardy-Weinberg equilibrium. Positive rates of genotype detection were 99.9% for rs2241715, 99.3% for rs6957 and 99.6% for the rest of the SNPs.
###end p 28
###begin title 29
Statistical analysis
###end title 29
###begin p 30
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R18">18</xref>
To assess genotype, allele and haplotype frequencies, Pearson's chi-square and/or Fisher's exact tests were performed when appropriate with SPSS 13.0 software. Haplotype analysis was carried out by HaploView [18], and the permutation test of this analysis was set to 100 000 permutations for single markers and haplotypes. For meta-analysis, the Mantel-Haenszel method was employed with a fixed effect and 95% confidence interval (95% CI) for odds ratio. Power calculation was performed for the two-tailed or one-tailed test when appropriate for 5% threshold of significance.
###end p 30
###begin title 31
Results
###end title 31
###begin title 32
###xml 79 87 <span type="species:ncbi:9606">patients</span>
Genotype frequencies of TGFB1 polymorphisms in male and female IgA nephropathy patients and healthy controls
###end title 32
###begin p 33
###xml 194 199 194 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 265 266 265 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 444 445 444 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 568 569 568 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 699 700 697 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 43 51 <span type="species:ncbi:9606">patients</span>
###xml 57 60 <span type="species:ncbi:9606">men</span>
###xml 76 81 <span type="species:ncbi:9606">women</span>
###xml 121 124 <span type="species:ncbi:9606">men</span>
###xml 141 146 <span type="species:ncbi:9606">women</span>
###xml 351 359 <span type="species:ncbi:9606">patients</span>
We genotyped 212 unrelated IgA nephropathy patients, 146 men (68.9%) and 66 women (31.1%), and 477 healthy subjects, 321 men (67.3%) and 156 women (32.7%), for five various polymorphisms of the TGFB1 gene. The minor allelic frequencies (MAF) are presented in Table 2. A significant difference between the genotype distribution in male IgA nephropathy patients and male healthy controls was found in a co-dominant model for all five SNPs (Table 3a). After the Bonferroni correction for multiple comparisons, four out of five SNPs remained significantly associated with P </= 0.05. Genotype frequencies for studied SNPs in the female study group did not, however, show a significant difference (Table 3b).
###end p 33
###begin p 34
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 87 95 <span type="species:ncbi:9606">patients</span>
Genotype frequencies of TGFB1 polymorphisms in (a) male and (b) female IgA nephropathy patients in a co-dominant model
###end p 34
###begin p 35
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aUncorrected.
###end p 35
###begin p 36
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
bTotal number for different variations may be different due to genotyping failure.
###end p 36
###begin p 37
###xml 66 67 66 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 87 88 87 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
###xml 149 150 149 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">5</xref>
###xml 308 309 308 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 324 325 324 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
###xml 514 515 514 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 527 528 527 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 942 943 942 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 957 958 957 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 989 990 989 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">5</xref>
###xml 1060 1061 1060 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1556 1561 1556 1561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 1684 1685 1684 1685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
###xml 1691 1692 1691 1692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">5</xref>
###xml 280 288 <span type="species:ncbi:9606">patients</span>
###xml 914 922 <span type="species:ncbi:9606">patients</span>
The allele and haplotype frequencies with experimental chi-square P-values and empiric P-values after permutation test are presented in Tables 4 and 5. When comparing the frequency of alleles, we found significant differences for rs2241715, rs1982073 and rs1800469 comparing male patients and male controls (P < 0.02, Table 4a). To check for possible false positive associations, we performed a permutation test with 100 000 permutations simultaneously for single markers and haplotypes, which resulted in empiric P = 0.04 and P = 0.02 for rs1800469 and rs1982073, respectively. A relatively high degree of linkage disequilibrium (LD) was detected in this locus, which resulted in 5 observed out of 32 expected haplotypes, which made it relatively easy to reveal genetic variability with the selected number of SNPs. Two out of five marker haplotypes, TGGCG and CTGTA, showed a significant difference between male patients and male controls (P = 0.0012 and P = 0.0018, respectively, Table 5a), and these two haplotypes passed the permutation test with empiric P = 0.006 and 0.008, respectively. These haplotypes represent either protective (TGGCG) or susceptible (CTGTA) variants and are opposite in four out of five alleles. The protective TGGCG haplotype comprises 56.4% of all chromosomes in the control male population and the CTGTA represents only 5.7%. The former number corresponds to 90% and the latter to 86% power of analysis to detect significant difference at 0.05 threshold in the two-tailed test. We found no indication for an association of TGFB1 gene polymorphism with disease in females in the allelic model nor in the haplotype analysis for this study group (Tables 4b and 5b).
###end p 37
###begin p 38
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 86 94 <span type="species:ncbi:9606">patients</span>
Allelic frequencies of TGFB1 polymorphisms in (a) male and (b) female IgA nephropathy patients and healthy controls
###end p 38
###begin p 39
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aUncorrected.
###end p 39
###begin p 40
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 88 96 <span type="species:ncbi:9606">patients</span>
Haplotype frequencies of TGFB1 polymorphisms in (a) male and (b) female IgA nephropathy patients and healthy controls
###end p 40
###begin p 41
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aUncorrected.
###end p 41
###begin title 42
Correlations between genotypes and progression of IgA nephropathy
###end title 42
###begin p 43
###xml 89 97 <span type="species:ncbi:9606">patients</span>
###xml 139 147 <span type="species:ncbi:9606">patients</span>
###xml 199 207 <span type="species:ncbi:9606">patients</span>
###xml 262 270 <span type="species:ncbi:9606">patients</span>
Using the disease severity criteria defined in the 'Materials and methods' section in 95 patients with available clinical data, 52 (54.7%) patients were classified as having benign disease, 19 (20%) patients had moderate renal disease progression and 24 (25.3%) patients had severe renal disease progression. No significant differences in genotype frequencies in either the co-dominant model or the dominant/recessive model were observed among the different severity groups with or without stratification for gender (data not shown).
###end p 43
###begin title 44
Meta-analysis
###end title 44
###begin p 45
###xml 107 112 107 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 220 224 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R9 R10">9,10</xref>
###xml 225 230 225 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R13 R14">13,14</xref>
###xml 526 531 526 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 604 609 604 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 684 689 684 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 699 704 699 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 808 813 808 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 926 931 926 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 1008 1012 1008 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R9 R10">9,10</xref>
###xml 1013 1015 1013 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R13">13</xref>
###xml 1031 1033 1031 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R10">10</xref>
###xml 1034 1036 1034 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R13">13</xref>
###xml 1102 1107 1102 1107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 1141 1142 1141 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R9">9</xref>
###xml 1726 1727 1726 1727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 1750 1755 1750 1755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 359 367 <span type="species:ncbi:9606">patients</span>
###xml 897 904 <span type="species:ncbi:9606">patient</span>
By searching information from PubMed and ISI Web of Knowledge, we found four published articles related to TGFB1 gene polymorphisms in IgA nephropathy in four different populations: Korean, Japanese, Italian and German [9,10,13,14]. No additional data were found in abstracts or proceedings. All papers had used similar selection criteria for IgA nephropathy patients compared to our study; however, selection of control groups differed from our study and stratification for gender was not done. Only in the study by Carturan et al., the control group was age- and gender-matched. In the study of Bantis et al., controls were matched by age, but not by gender. In the studies by Sato et al. and Lim et al., the control groups were discordant for age and for gender ratio. All studies except that by Carturan et al. reported that individuals in the control groups were of the same ethnicity as the patient groups. At least two TGFB1 polymorphisms (rs1982073 and rs1800469) were investigated in three studies [9,10,13]. Two studies [10,13] were included in meta-analysis together with our data for these TGFB1 markers. In the remaining study [9], the frequency of the genotype distribution for the rs1982073 significantly deviated from Hardy-Weinberg equilibrium, which questions the validity of the data. For this reason, we decided to exclude this particular study from the meta-analysis. As we could only use the frequency of variations for the combined group of both genders in the previously published studies, our own data were also not stratified by gender for the meta-analysis. The Mantel-Haenszel method with fixed effect demonstrated a significant cumulative odds ratio for rs1982073 (0.77, 95% CI 0.61-0.97) (Figure 1), suggesting that the TGFB1 gene polymorphism is associated with IgA nephropathy in the studied populations. In addition, rs1800469 showed a trend for association with disease susceptibility, which did not reach statistical significance in the meta-analysis (0.86, 95% CI 0.69-1.07). Both genetic markers displayed a protective effect for the common genotype (CC and GG respectively) and passed the test for heterogeneity between the studies.
###end p 45
###begin p 46
Meta-analysis with rs1800469 in two different populations and our own data; the genetic marker displayed a protective effect for the common genotype with CC and passed test for heterogeneity between the studies.
###end p 46
###begin title 47
Discussion
###end title 47
###begin p 48
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
In the present study, we demonstrate an association of the TGFB1 gene polymorphism with IgA nephropathy. Our own data, together with the meta-analysis of previously published data, provide a strong indication of the importance of TGFbeta1 in the development of IgA nephropathy.
###end p 48
###begin p 49
###xml 269 270 269 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R3">3</xref>
###xml 271 276 271 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R19 R20 R21 R22">19&#8211;22</xref>
###xml 608 610 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R23">23</xref>
###xml 645 650 638 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R24 R25 R26">24&#8211;26</xref>
###xml 666 671 659 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R27 R28">27,28</xref>
###xml 711 716 704 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R29 R30">29,30</xref>
###xml 757 762 750 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R31 R32">31,32</xref>
###xml 800 802 793 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R33">33</xref>
###xml 881 888 <span type="species:ncbi:9606">patient</span>
Previously, both linkage and association studies have been utilized to study the susceptibility risk factors for IgA nephropathy. Using genome-wide linkage microsatellite analysis, a linkage of IgA nephropathy to 2q36, 6q22-23, 4q26-31 and 17q12-22 has been suggested [3,19-22]. However, no obvious candidate genes within these linkage regions have so far been identified. Several candidate gene polymorphism association studies have previously been performed to explore the role of several genes that could be related to the susceptibility to and the progression of IgA nephropathy, including MHC class II [23], T-cell receptor alpha and beta [24-26], uteroglobin [27,28], angiotensin-converting enzyme (ACE) [29,30], other renin-angiotensin system genes [31,32], as well as several cytokine genes [33]. However, some of these studies have shown contradictory results, and larger patient populations with an optimal study design are required to establish the role of specific genes in the susceptibility to IgA nephropathy. Although most studies used ethnically homogeneous study populations, the gender effect was not assessed in any of those investigations.
###end p 49
###begin p 50
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 265 270 265 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 68 76 <span type="species:ncbi:9606">patients</span>
In our analysis of five TGFB1 gene polymorphisms in a cohort of 212 patients with IgA nephropathy and 477 age-, gender- and ethnicity-matched controls, we were able to demonstrate, with reasonable statistical power, an association between genetic variations in the TGFB1 gene and the susceptibility to IgA nephropathy in males. A meta-analysis of previously published data from two independent studies together with our results strengthens this conclusion.
###end p 50
###begin p 51
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 126 130 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R9 R10">9,10</xref>
###xml 131 136 131 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R13 R14">13,14</xref>
###xml 213 218 213 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R10">10</xref>
###xml 737 738 737 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R9">9</xref>
###xml 1015 1020 1015 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 1227 1229 1225 1227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R14">14</xref>
###xml 1268 1273 1266 1271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 1429 1431 1425 1427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R13">13</xref>
###xml 178 186 <span type="species:ncbi:9606">patients</span>
###xml 685 693 <span type="species:ncbi:9606">patients</span>
###xml 1142 1150 <span type="species:ncbi:9606">patients</span>
###xml 1373 1381 <span type="species:ncbi:9606">patients</span>
There are four previous studies addressing the importance of the TGFB1 gene in IgA nephropathy in four different populations [9,10,13,14]. In the study performed in 329 Japanese patients with IgA nephropathy, two TGFB1 gene polymorphisms (rs1982073 and rs1800469) were shown to associate with heavy proteinuria and mesangial glomerular proliferation. This is at the moment the largest published genetic study of IgA nephropathy. However, no association with susceptibility to IgA nephropathy was demonstrated [10]. In the study from South Korea, analysing two SNPs, C-509T and T869C (rs1982073 and rs1800469), a significant difference in the genotype frequency was found comparing 108 patients with IgA nephropathy and healthy controls [9]. Since the reported frequencies of the rs1800469 genotypes significantly deviated from Hardy-Weinberg equilibrium, these data have to be taken with some caution. Two other studies were done in Europe in Caucasians with IgA nephropathy. In the study performed in Germany, one TGFB1 SNP, rs1800471 (C915G or codon 25, arginine-->proline), showed the similar genotype distribution between IgA nephropathy patients and controls as well as between the progression and non-progression groups [14]. Finally, in an Italian study, three TGFB1 SNPs, Leu10-->Pro (rs1982073), C-509T (rs1800469) and G-800A (rs1800468), were investigated in 101 patients with IgA nephropathy and 118 healthy controls [13]. A significant association was observed in the haplotype analysis, but genotype frequencies did not reach significant statistical difference.
###end p 51
###begin p 52
###xml 149 154 149 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 227 232 227 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R10">10</xref>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R13">13</xref>
###xml 728 733 728 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 853 861 853 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post hoc</italic>
###xml 820 828 <span type="species:ncbi:9606">patients</span>
Three previous studies have demonstrated either a tendency for an association or a significant association with at least some genetic markers in the TGFB1 gene. We performed a meta-analysis in order to further test the role of TGFB1 in the susceptibility to IgA nephropathy. In the meta-analysis, we combined our new findings and data with those obtained in two of the previously published studies [10,13] and included two genetic markers (rs1982073 and rs1800469) that were investigated in all of the studies. Due to the fact that data in previous studies could not be stratified by gender, we combined the female and male groups in our study into one group for this specific test. This meta-analysis supported the role of the TGFB1 gene in the development of IgA nephropathy in a combined group of 640 IgA nephropathy patients and 880 controls with a post hoc power estimate of 96% for the one-tailed test. However, this must be taken with caution due to a possible bias towards publishing of positive associations. It is also important to perform further extension of the study to get better statistical power to detect an association. Another way of addressing a lack of power could be replication of the association in independent cohorts.
###end p 52
###begin p 53
###xml 750 755 738 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 1035 1040 1023 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R34 R35">34,35</xref>
###xml 1106 1113 <span type="species:ncbi:9606">patient</span>
However, it is possibly premature to claim functional consequences from any of the analysed variations, due to a strong pattern of LD in this region. In fact, three markers from our study (rs1800469, rs1982073 and rs1800471) belong to the recombination block with high LD (D'approximately1.0), which means that any variation in this region may be in association with a certain phenotype, because of its close position to the mutual causal allele. This is a strong indication of either a true importance of the combination of common alleles, which were selected for our study, or for an unknown causal variation, which is in high LD with the analysed single-nucleotide polymorphisms (SNPs). In both cases, it is evident that genetic variations in the TGFB1 locus could be important contributors to disease development. It is also noteworthy to mention that the genetic landscape of variations in this locus seems to be very different in Caucasian and Chinese or Japanese populations and allelic frequencies are significantly different [34,35]. This must be taken into account in future studies of different patient populations. We excluded non-Caucasians from the current study to avoid extensive population admixture, but a proper genomic control in our study was not possible due to the limited number of included SNPs. Another potential difficulty is the failure in genotyping of some variations in this locus: out of nine tested SNP assays only four demonstrated a robust performance and were selected for our genetic study, which may illustrate either a high homology of sequences flanking these variations with other genetic regions or a high frequency of copy number polymorphisms in this locus.
###end p 53
###begin p 54
###xml 139 147 <span type="species:ncbi:9606">patients</span>
In our study, no significant differences in genotype frequencies between the non-progression and the progression groups of IgA nephropathy patients with impaired renal function could be demonstrated.
###end p 54
###begin p 55
###xml 117 122 117 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 341 346 341 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
In summary, by using our own experimental data and a meta-analysis of previously published data, we propose that the TGFB1 gene is an important contributor for the susceptibility to IgA nephropathy. Additional replication for such association and further studies are warranted to investigate disease mechanisms and the physiological role of TGFB1 in the development of kidney diseases. Moreover, we suggest considering the effect of gender in such studies.
###end p 55
###begin p 56
We would like to thank Eva Jemseby, Per-Anton Westerberg, Susanne Schepull, Micael Gylling and Per Eriksson for their helpful assistance. Dr Jarl Ahlmen's involvement at the initial stage of this study is highly appreciated. We are grateful for the support by the Sida/SAREC, Roche, and The Fund for Renal Research (Heart and Lung Foundation), Sweden.
###end p 56
###begin p 57
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 57
###begin p 58
###xml 120 143 120 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nephrol Dial Transplant</italic>
(See related article by M. Barua and Y. Pei. Identifying susceptibility genes of IgA nephropathy: research in progress. Nephrol Dial Transplant 2009; 24: 2957-2959.)
###end p 58
###begin title 59
References
###end title 59
###begin article-title 60
A retrospective analysis of the natural history of primary IgA nephropathy worldwide
###end article-title 60
###begin article-title 61
Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors
###end article-title 61
###begin article-title 62
Familial IgA nephropathy. Evidence of an inherited mechanism of disease
###end article-title 62
###begin article-title 63
IgA nephropathy
###end article-title 63
###begin article-title 64
###xml 83 89 <span type="species:ncbi:10090">murine</span>
Smad3 and Smad4 mediate transforming growth factor-beta1-induced IgA expression in murine B lymphocytes
###end article-title 64
###begin article-title 65
Transforming growth factor-beta in disease: the dark side of tissue repair
###end article-title 65
###begin article-title 66
Transforming growth factor-beta and the pathogenesis of glomerular diseases
###end article-title 66
###begin article-title 67
Association of TGF-beta1 polymorphisms with chronic renal disease
###end article-title 67
###begin article-title 68
Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with susceptibility to and progression of IgA nephropathy
###end article-title 68
###begin article-title 69
###xml 117 125 <span type="species:ncbi:9606">patients</span>
Transforming growth factor-beta1 gene polymorphism modifies the histological and clinical manifestations in Japanese patients with IgA nephropathy
###end article-title 69
###begin article-title 70
Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis
###end article-title 70
###begin article-title 71
Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation
###end article-title 71
###begin article-title 72
Association between transforming growth factor beta1 gene polymorphisms and IgA nephropathy
###end article-title 72
###begin article-title 73
Influence of cytokine gene polymorphisms on IgA nephropathy
###end article-title 73
###begin article-title 74
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation
###end article-title 74
###begin article-title 75
###xml 16 21 <span type="species:ncbi:9606">human</span>
Distribution of human kappa locus IGKV2-29 and IGKV2D-29 alleles in Swedish Caucasians and Hong Kong Chinese
###end article-title 75
###begin article-title 76
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Transforming growth factor beta 1 gene polymorphism in Japanese patients with systemic lupus erythematosus
###end article-title 76
###begin article-title 77
Haploview: analysis and visualization of LD and haplotype maps
###end article-title 77
###begin article-title 78
Genetic heterogeneity in Italian families with IgA nephropathy: suggestive linkage for two novel IgA nephropathy loci
###end article-title 78
###begin article-title 79
IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23
###end article-title 79
###begin article-title 80
Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36
###end article-title 80
###begin article-title 81
IgA nephropathy: a clinical overview
###end article-title 81
###begin article-title 82
###xml 107 115 <span type="species:ncbi:9606">patients</span>
Single-nucleotide polymorphisms in the class II region of the major histocompatibility complex in Japanese patients with immunoglobulin a nephropathy
###end article-title 82
###begin article-title 83
T-cell homing receptor expression in IgA nephropathy
###end article-title 83
###begin article-title 84
###xml 120 128 <span type="species:ncbi:9606">patients</span>
Association of a T-cell receptor constant alpha chain gene polymorphism with progression of IgA nephropathy in Japanese patients
###end article-title 84
###begin article-title 85
Association of IgA nephropathy with T-cell receptor constant alpha chain gene polymorphism
###end article-title 85
###begin article-title 86
Association of the uteroglobin gene polymorphism with IgA nephropathy
###end article-title 86
###begin article-title 87
Clinical aspects of Clara cell 10-kDa protein/uteroglobin (secretoglobin 1A1)
###end article-title 87
###begin article-title 88
Angiotensin antagonists and fish oil for treating IgA nephropathy
###end article-title 88
###begin article-title 89
IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors
###end article-title 89
###begin article-title 90
Polymorphisms of renin-angiotensin system genes in childhood IgA nephropathy
###end article-title 90
###begin article-title 91
The renin-angiotensin system gene polymorphisms and clinicopathological correlations in IgA nephropathy
###end article-title 91
###begin article-title 92
Pathogenesis of IgA nephropathy
###end article-title 92
###begin article-title 93
A catalog of 106 single-nucleotide polymorphisms (SNPs) and 11 other types of variations in genes for transforming growth factor-beta1 (TGF-beta1) and its signaling pathway
###end article-title 93
###begin article-title 94
###xml 70 78 <span type="species:ncbi:9606">patients</span>
The polymorphism of transforming growth factor-beta1 gene in Japanese patients with systemic sclerosis
###end article-title 94

